[1]
E. H. Ali and B. Denis, “A Case Series of 13 Patients with COVID-19 Associated Respiratory Symptoms Treated with Nebulized OTR4120 (Cacipliq20®)”, acmcr, vol. 6, no. 4, pp. 604–610, Aug. 2022.